Cramer: Disney Should Norwegian a Bold Cruise Play Now
A bold claim from Jim Cramer has reignited the debate over Disney buying Norwegian Cruise Line. With shipyard bottlen...
When To Choose Long Term Investing Over Short Term
Understand when to opt for long term investing over short term to maximize your investment returns. Discover the key factors influencing your decision.
28,006 articles
American Electric Power Vernova: Which Utilities Stock Is a Better Buy in 2026?
As the power transition accelerates, two giants—American Electric Power and GE Vernova—offer very different routes fo...
Officials Closely Monitor Iran as Fed Watches Inflation Pulse
As the Iran conflict returns energy markets to sharper swings, officials closely monitor iran for signs inflation cou...
Spacex's Acquisition Cursor Could Be a Major Bargain for Investors
SpaceX eyes Cursor AI in a deal that could redefine tech investing. This analysis explains why spacex's acquisition c...
Intuitive Surgical Upgraded by Citi Signals New Buy Cycle
Citi upgrades Intuitive Surgical to Buy as market volatility eases, with Stryker placed on a 90-day catalyst watch an...
This Stock Will Dominate the Second Half of 2026 Markets
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
Here's Shares Delek Soared: What Fueled the Move
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Breaking Binance News Affecting European Clients Today
Binance withdraws its MiCA filing in Greece, signaling a broader EU strategy as July 1 approaches. European users fac...
Southern Company Risk Looks Subdued as Policy Fears Fade
As Alabama lawmakers move toward compromise on utility bills, investors argue that southern company risk looks more m...
Oracle Could Be a Trillion-Dollar Company by 2030: Advances
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Micron Turning Into Steadier Growth: Is MU Stock Ready
Is micron turning into steadier growth possible for MU? This article breaks down the AI memory demand cycle, MU's str...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status